These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 15915713

  • 1. [PC-12 cells hydrolyze the fibrin clot by producing both plasminogen and its tissue activator].
    Petrova IuI, Savchuk OM, Kalashnyk OM, Platonova TM, Skok MV, Cederholm-Williams S.
    Ukr Biokhim Zh (1999); 2004; 76(2):64-8. PubMed ID: 15915713
    [Abstract] [Full Text] [Related]

  • 2. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI, Leslie B, Ginsberg J.
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [Abstract] [Full Text] [Related]

  • 3. Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites.
    Yakovlev S, Makogonenko E, Kurochkina N, Nieuwenhuizen W, Ingham K, Medved L.
    Biochemistry; 2000 Dec 26; 39(51):15730-41. PubMed ID: 11123898
    [Abstract] [Full Text] [Related]

  • 4. [The effect of kringles K1-3, K4 and K5 on lysis of fibrin clots caused by the activation of Glu- and Lys-plasminogen by a tissue activator].
    Taran LD, Makogonenko EM.
    Ukr Biokhim Zh (1978); 1989 Dec 26; 61(4):31-6. PubMed ID: 2511651
    [Abstract] [Full Text] [Related]

  • 5. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ, Stafford AR, Leslie BA, Kim PY, Vaezzadeh N, Ni R, Fredenburgh JC, Weitz JI.
    Thromb Haemost; 2015 Jun 26; 113(6):1278-88. PubMed ID: 25789495
    [Abstract] [Full Text] [Related]

  • 6. [Plasminogen activation by tissue plasminogen activator on fibrin clots with different surface structures].
    Savchuk AN.
    Ukr Biokhim Zh (1999); 2001 Jun 26; 73(3):87-90. PubMed ID: 12035559
    [Abstract] [Full Text] [Related]

  • 7. Enhanced fibrinolysis by proteolysed coagulation factor Xa.
    Talbot K, Meixner SC, Pryzdial EL.
    Biochim Biophys Acta; 2010 Apr 26; 1804(4):723-30. PubMed ID: 19931652
    [Abstract] [Full Text] [Related]

  • 8. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF, Pandi L.
    Biochemistry; 2006 Feb 28; 45(8):2657-67. PubMed ID: 16489759
    [Abstract] [Full Text] [Related]

  • 9. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
    Wu JH, Diamond SL.
    J Clin Invest; 1995 Jun 28; 95(6):2483-90. PubMed ID: 7769094
    [Abstract] [Full Text] [Related]

  • 10. Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator.
    Stewart RJ, Fredenburgh JC, Rischke JA, Bajzar L, Weitz JI.
    J Biol Chem; 2000 Nov 24; 275(47):36612-20. PubMed ID: 10970891
    [Abstract] [Full Text] [Related]

  • 11. [Proteolytic activity of the Glu-plasminogen complex with fibrinogen fragment E].
    Skomorovskaia EV, Grinenko TV, Kudinov SA, Zolotareva EN.
    Biokhimiia; 1991 Mar 24; 56(3):458-66. PubMed ID: 1883906
    [Abstract] [Full Text] [Related]

  • 12. High accumulation of plasminogen and tissue plasminogen activator at the flow surface of mural fibrin in the human arterial system.
    Sasajima T, Takano Y, Hiraishi Y, Goh K, Inaba M, Azuma N, Sasajima Y, Yamazaki K, Yamamoto H.
    J Vasc Surg; 2000 Aug 24; 32(2):374-82. PubMed ID: 10917998
    [Abstract] [Full Text] [Related]

  • 13. [Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system].
    Cao YJ, Wu YH, Liu CF.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan 24; 36(1):62-7. PubMed ID: 19099932
    [Abstract] [Full Text] [Related]

  • 14. Fibrin-specific fibrinolysis.
    Collen D, Lijnen HR.
    Ann N Y Acad Sci; 1992 Dec 04; 667():259-71. PubMed ID: 1285022
    [No Abstract] [Full Text] [Related]

  • 15. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J, Aleem AM, Selman SH, Skrzypczak-Jankun E, Lysiak-Szydlowska W, Grafos N, Fryer HJ, Greenfield RS.
    Int J Mol Med; 2007 Nov 04; 20(5):683-7. PubMed ID: 17912461
    [Abstract] [Full Text] [Related]

  • 16. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
    Eisenberg PR, Jaffe AS, Stump DC, Collen D, Bovill EG.
    Circulation; 1990 Oct 04; 82(4):1159-68. PubMed ID: 2119264
    [Abstract] [Full Text] [Related]

  • 17. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA, Leonova VB, Khavkina LS.
    Izv Akad Nauk SSSR Biol; 1991 Oct 04; (3):334-42. PubMed ID: 1835465
    [Abstract] [Full Text] [Related]

  • 18. [Plasminogen-binding centers of molecules of fibrinogen, fibrin and products of their proteolysis].
    Grinenko TV, Tret'iachenko VG, Kudinov SA, Medved' LV.
    Biokhimiia; 1987 Oct 04; 52(10):1732-9. PubMed ID: 3427134
    [Abstract] [Full Text] [Related]

  • 19. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis.
    Jones AJ, Meunier AM.
    Thromb Haemost; 1990 Nov 30; 64(3):455-63. PubMed ID: 2128976
    [Abstract] [Full Text] [Related]

  • 20. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
    Hare TR, Gardell SJ.
    Thromb Haemost; 1992 Aug 03; 68(2):165-9. PubMed ID: 1412162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.